Position in WAT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,204,286
+$3,498,476 QoQ
Shares Held
16,543
+82.1% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#244
of 1,173 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in WAT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $8,344,686 across 9 Diagnostics & Research names. WAT ranks #1 (74.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
This page
|
16,543 | $6,204,286 | |
| 2 | DHR |
Danaher Corp /De/
|
6,169 | $1,175,070 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
1,655 | $829,749 | |
| 4 | LH |
Labcorp Holdings Inc.
|
241 | $67,480 | |
| 5 | DGX |
Quest Diagnostics Inc
|
137 | $29,037 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
56 | $12,700 | |
| 7 | FLGT |
Fulgent Genetics, Inc.
|
500 | $10,260 | |
| 8 | ILMN |
Illumina, Inc.
|
48 | $8,439 |
All Filings in WAT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,204,286 | 16,543 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,705,810 | 9,086 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,006 | 79 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,197 | 14 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,886 | 14 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,897 | 16 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,935 | 16 | Shares | Sole | 2025-02-14 | |
| 2023-09-30 | $61,697 | 225 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $69,300 | 260 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $80,503 | 260 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $77,080 | 225 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||